Study Design and First Results of a Non-Interventional Registry Study To Establish Long-Term Safety and Pharmaco-Economic Data on Fingolimod (Gilenya®) in Multiple Sclerosis Patients in Germany (PANGAEA)

被引：0
|
作者：
Ziemssen, Tjalf [1 ]
van Lokven, Tom [2 ]
Kempke, Raimar [1 ]
Meergans, Matthias [2 ]
机构：
[1] Carl Gustav Carus Univ Hosp, Ctr Clin Neurosci, Dresden, Germany
[2] CNS Novartis Pharma GmbH, Clin Res, Nurnberg, Germany
来源：
NEUROLOGY | 2012年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P04131
引用
收藏
页数：2
相关论文
共 50 条
  • [41] ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritis
    Specker, C.
    Alberding, A.
    Aringer, M.
    Burmester, G-R
    Flacke, J-P
    Hofmann, M. W.
    Kaestner, P.
    Kellner, H.
    Moosig, F.
    Sieburg, M.
    Tony, H-P
    Fliedner, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (02) : 319 - 328
  • [42] Treatment patterns and long-term clinical outcomes in Chinese patients with nonmetastatic gastric cancer: Results from the non-interventional EVIDENCE registry study
    Ji, Jiafu
    Qin, Shukui
    Wang, Xin
    Zhou, Weiping
    Chen, Lin
    Zheng, Zhichao
    Su, Wuyun
    Zhang, Helong
    Wang, Jianhua
    Luo, Qi
    Tang, Yong
    Shen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [43] Interim results (3-year) of a French non-interventional study to assess the long-term safety and efficacy of BeneFIX
    Rothschild, C.
    Trossaert, M.
    Claeyssens-Donadel, S.
    Lambert, T.
    Hassoun, A.
    Volot, F.
    Attal, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 428 - 428
  • [44] Interim results (2-year) of a French non-interventional study to assess the long-term safety and efficacy of BeneFIX
    Rothschild, C.
    Trossaert, M.
    Claeyssens, S.
    Lambert, T.
    Hassoun, A.
    Volot, F.
    Dubanchet, A.
    HAEMOPHILIA, 2012, 18 : 23 - 24
  • [45] X-Tab: Non-interventional long-term study of omalizumab therapy in severe allergic asthmatic patients in Germany
    Schreiber, J.
    Mailaender, C.
    ALLERGY, 2018, 73 : 203 - 204
  • [46] A non-interventional long-term study with MCT® (microcrystalline L-tyrosine)-adsorbed allergoids first interim results of the TAPAS study
    Moesges, R.
    Gerstlauer, M.
    Allekotte, S.
    England, L.
    Neuhof, C.
    Sahin, H.
    Hebbeler, K.
    Karahan, N.
    Ugur, S.
    Kramer, M. F.
    Raab, J.
    ALLERGOLOGIE, 2022, 45 (08) : 600 - 600
  • [47] Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study
    Saida, Takahiko
    Itoyama, Yasuto
    Kikuchi, Seiji
    Hao, Qi
    Kurosawa, Takayoshi
    Ueda, Kengo
    Auberson, Lixin Zhang
    Tsumiyama, Isao
    Nagato, Kazuo
    Kira, Jun-ichi
    BMC NEUROLOGY, 2017, 17
  • [48] Long-Term Safety of Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: Results from Phase 3 FREEDOMS II Extension Study
    Vollmer, Timothy
    Jeffery, Douglas
    Goodin, Douglas
    Kappos, Ludwig
    Lublin, Fred
    Radue, Ernst-Wilhelm
    Rammohan, Kottil
    Reder, Anthony
    Agius, Mark
    Stites, Tracy
    Li, Bingbing
    Cappiello, Linda
    von Rosenstiel, Philipp
    Calabresi, Peter
    NEUROLOGY, 2013, 80
  • [49] Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study
    Takahiko Saida
    Yasuto Itoyama
    Seiji Kikuchi
    Qi Hao
    Takayoshi Kurosawa
    Kengo Ueda
    Lixin Zhang Auberson
    Isao Tsumiyama
    Kazuo Nagato
    Jun-ichi Kira
    BMC Neurology, 17
  • [50] A systematic review of non-interventional studies reporting on humanistic and economic burden of cognitive decline in multiple sclerosis patients regardless of study design
    Wakeford, C.
    Bereza, B. G.
    Longo, C. J.
    Einarson, T. R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 533 - 533
12345